 | • レポートコード：MRC2012B0160 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん悪液質の世界市場を広く調査・分析し、今後の市場展望をまとめております。がん悪液質の種類別市場規模（プロゲストゲン、コルチコステロイド、併用療法）、用途別市場規模（病院薬局店、小売薬局店、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Aeterna Zentaris、Novartis、Eli Lilly、Alder BioPharmaceuticals、Merck、Aphios、XBiotech、Helsinn、GTx、Bristol-Myers Squibb、 ・地域別グローバル市場分析 2015年-2020年 ・がん悪液質の北米市場（アメリカ、カナダ、メキシコ） ・がん悪液質のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん悪液質のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん悪液質の南米市場（ブラジル、アルゼンチン） ・がん悪液質の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロゲストゲン、コルチコステロイド、併用療法 ・用途別分析：病院薬局店、小売薬局店、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cancer Cachexia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1917.4 million by 2025, from USD 1637 million in 2019.
The Cancer Cachexia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Cachexia market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Cachexia market has been segmented into:
Progestogens
Corticosteroids
Combination therapies
By Application, Cancer Cachexia has been segmented into:
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Cachexia market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Cachexia markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Cachexia market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Cachexia market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Cachexia Market Share Analysis
Cancer Cachexia competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Cachexia sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Cachexia sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Cachexia are:
Aeterna Zentaris
Novartis
Eli Lilly
Alder BioPharmaceuticals
Merck
Aphios
XBiotech
Helsinn
GTx
Bristol-Myers Squibb
Table of Contents
1 Cancer Cachexia Market Overview
1.1 Product Overview and Scope of Cancer Cachexia
1.2 Classification of Cancer Cachexia by Type
1.2.1 Global Cancer Cachexia Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Cachexia Revenue Market Share by Type in 2019
1.2.3 Progestogens
1.2.4 Corticosteroids
1.2.5 Combination therapies
1.3 Global Cancer Cachexia Market by Application
1.3.1 Overview: Global Cancer Cachexia Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Stores
1.3.3 Retails Pharmacy Store
1.3.4 Online Pharmacy
1.4 Global Cancer Cachexia Market by Regions
1.4.1 Global Cancer Cachexia Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Cachexia (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Cachexia Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Cachexia Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Cachexia Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Cachexia Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Cachexia Status and Prospect (2015-2025)
2 Company Profiles
2.1 Aeterna Zentaris
2.1.1 Aeterna Zentaris Details
2.1.2 Aeterna Zentaris Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aeterna Zentaris SWOT Analysis
2.1.4 Aeterna Zentaris Product and Services
2.1.5 Aeterna Zentaris Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alder BioPharmaceuticals
2.4.1 Alder BioPharmaceuticals Details
2.4.2 Alder BioPharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Alder BioPharmaceuticals SWOT Analysis
2.4.4 Alder BioPharmaceuticals Product and Services
2.4.5 Alder BioPharmaceuticals Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aphios
2.6.1 Aphios Details
2.6.2 Aphios Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aphios SWOT Analysis
2.6.4 Aphios Product and Services
2.6.5 Aphios Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.7 XBiotech
2.7.1 XBiotech Details
2.7.2 XBiotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 XBiotech SWOT Analysis
2.7.4 XBiotech Product and Services
2.7.5 XBiotech Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.8 Helsinn
2.8.1 Helsinn Details
2.8.2 Helsinn Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Helsinn SWOT Analysis
2.8.4 Helsinn Product and Services
2.8.5 Helsinn Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.9 GTx
2.9.1 GTx Details
2.9.2 GTx Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GTx SWOT Analysis
2.9.4 GTx Product and Services
2.9.5 GTx Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Cancer Cachexia Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Cachexia Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Cachexia Players Market Share
3.2.2 Top 10 Cancer Cachexia Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Cachexia Revenue and Market Share by Regions
4.2 North America Cancer Cachexia Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Cachexia Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Cachexia Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Cachexia Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Cachexia Revenue and Growth Rate (2015-2020)
5 North America Cancer Cachexia Revenue by Countries
5.1 North America Cancer Cachexia Revenue by Countries (2015-2020)
5.2 USA Cancer Cachexia Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Cachexia Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Cachexia Revenue and Growth Rate (2015-2020)
6 Europe Cancer Cachexia Revenue by Countries
6.1 Europe Cancer Cachexia Revenue by Countries (2015-2020)
6.2 Germany Cancer Cachexia Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Cachexia Revenue and Growth Rate (2015-2020)
6.4 France Cancer Cachexia Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Cachexia Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Cachexia Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Cachexia Revenue by Countries
7.1 Asia-Pacific Cancer Cachexia Revenue by Countries (2015-2020)
7.2 China Cancer Cachexia Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Cachexia Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Cachexia Revenue and Growth Rate (2015-2020)
7.5 India Cancer Cachexia Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Cachexia Revenue and Growth Rate (2015-2020)
8 South America Cancer Cachexia Revenue by Countries
8.1 South America Cancer Cachexia Revenue by Countries (2015-2020)
8.2 Brazil Cancer Cachexia Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Cachexia Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Cachexia by Countries
9.1 Middle East & Africa Cancer Cachexia Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Cachexia Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Cachexia Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Cachexia Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Cachexia Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Cachexia Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Cachexia Market Forecast by Type (2019-2024)
10.3 Progestogens Revenue Growth Rate (2015-2025)
10.4 Corticosteroids Revenue Growth Rate (2015-2025)
10.5 Combination therapies Revenue Growth Rate (2015-2025)
11 Global Cancer Cachexia Market Segment by Application
11.1 Global Cancer Cachexia Revenue Market Share by Application (2015-2020)
11.2 Cancer Cachexia Market Forecast by Application (2019-2024)
11.3 Hospital Stores Revenue Growth (2015-2020)
11.4 Retails Pharmacy Store Revenue Growth (2015-2020)
11.5 Online Pharmacy Revenue Growth (2015-2020)
12 Global Cancer Cachexia Market Size Forecast (2021-2025)
12.1 Global Cancer Cachexia Market Size Forecast (2021-2025)
12.2 Global Cancer Cachexia Market Forecast by Regions (2021-2025)
12.3 North America Cancer Cachexia Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Cachexia Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Cachexia Revenue Market Forecast (2021-2025)
12.6 South America Cancer Cachexia Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Cachexia Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Cachexia Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Cachexia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Cachexia Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Cachexia Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Aeterna Zentaris Corporate Information, Location and Competitors
Table 6. Aeterna Zentaris Cancer Cachexia Major Business
Table 7. Aeterna Zentaris Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 8. Aeterna Zentaris SWOT Analysis
Table 9. Aeterna Zentaris Cancer Cachexia Product and Solutions
Table 10. Aeterna Zentaris Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novartis Corporate Information, Location and Competitors
Table 12. Novartis Cancer Cachexia Major Business
Table 13. Novartis Cancer Cachexia Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Cancer Cachexia Product and Solutions
Table 16. Novartis Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eli Lilly Corporate Information, Location and Competitors
Table 18. Eli Lilly Cancer Cachexia Major Business
Table 19. Eli Lilly Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 20. Eli Lilly SWOT Analysis
Table 21. Eli Lilly Cancer Cachexia Product and Solutions
Table 22. Eli Lilly Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Alder BioPharmaceuticals Corporate Information, Location and Competitors
Table 24. Alder BioPharmaceuticals Cancer Cachexia Major Business
Table 25. Alder BioPharmaceuticals Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 26. Alder BioPharmaceuticals SWOT Analysis
Table 27. Alder BioPharmaceuticals Cancer Cachexia Product and Solutions
Table 28. Alder BioPharmaceuticals Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Cancer Cachexia Major Business
Table 31. Merck Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Cancer Cachexia Product and Solutions
Table 34. Merck Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Aphios Corporate Information, Location and Competitors
Table 36. Aphios Cancer Cachexia Major Business
Table 37. Aphios Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 38. Aphios SWOT Analysis
Table 39. Aphios Cancer Cachexia Product and Solutions
Table 40. Aphios Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. XBiotech Corporate Information, Location and Competitors
Table 42. XBiotech Cancer Cachexia Major Business
Table 43. XBiotech Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 44. XBiotech SWOT Analysis
Table 45. XBiotech Cancer Cachexia Product and Solutions
Table 46. XBiotech Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Helsinn Corporate Information, Location and Competitors
Table 48. Helsinn Cancer Cachexia Major Business
Table 49. Helsinn Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 50. Helsinn SWOT Analysis
Table 51. Helsinn Cancer Cachexia Product and Solutions
Table 52. Helsinn Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GTx Corporate Information, Location and Competitors
Table 54. GTx Cancer Cachexia Major Business
Table 55. GTx Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 56. GTx SWOT Analysis
Table 57. GTx Cancer Cachexia Product and Solutions
Table 58. GTx Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Cancer Cachexia Major Business
Table 61. Bristol-Myers Squibb Cancer Cachexia Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb SWOT Analysis
Table 63. Bristol-Myers Squibb Cancer Cachexia Product and Solutions
Table 64. Bristol-Myers Squibb Cancer Cachexia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Cancer Cachexia Revenue (Million USD) by Players (2015-2020)
Table 66. Global Cancer Cachexia Revenue Share by Players (2015-2020)
Table 67. Global Cancer Cachexia Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Cancer Cachexia Revenue Market Share by Regions (2015-2020)
Table 69. North America Cancer Cachexia Revenue by Countries (2015-2020)
Table 70. North America Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Table 71. Europe Cancer Cachexia Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Cancer Cachexia Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Cancer Cachexia Revenue by Countries (2015-2020)
Table 74. South America Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Cancer Cachexia Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Table 77. Global Cancer Cachexia Revenue (Million USD) by Type (2015-2020)
Table 78. Global Cancer Cachexia Revenue Share by Type (2015-2020)
Table 79. Global Cancer Cachexia Revenue Forecast by Type (2021-2025)
Table 80. Global Cancer Cachexia Revenue by Application (2015-2020)
Table 81. Global Cancer Cachexia Revenue Share by Application (2015-2020)
Table 82. Global Cancer Cachexia Revenue Forecast by Application (2021-2025)
Table 83. Global Cancer Cachexia Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Cachexia Picture
Figure 2. Global Cancer Cachexia Revenue Market Share by Type in 2019
Figure 3. Progestogens Picture
Figure 4. Corticosteroids Picture
Figure 5. Combination therapies Picture
Figure 6. Cancer Cachexia Revenue Market Share by Application in 2019
Figure 7. Hospital Stores Picture
Figure 8. Retails Pharmacy Store Picture
Figure 9. Online Pharmacy Picture
Figure 10. Global Cancer Cachexia Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cancer Cachexia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cancer Cachexia Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Cancer Cachexia Revenue Market Share in 2019
Figure 19. Global Top 10 Players Cancer Cachexia Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Cancer Cachexia Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Cancer Cachexia Revenue Market Share by Regions (2015-2020)
Figure 23. Global Cancer Cachexia Revenue Market Share by Regions in 2018
Figure 24. North America Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 25. Europe Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 27. South America Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 29. North America Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Figure 30. North America Cancer Cachexia Revenue Market Share by Countries in 2019
Figure 31. USA Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 32. Canada Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 34. Europe Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Cancer Cachexia Revenue Market Share by Countries in 2019
Figure 36. Germany Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 37. UK Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 38. France Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 39. Russia Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 40. Italy Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Cancer Cachexia Revenue Market Share by Countries in 2019
Figure 43. China Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 44. Japan Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 45. Korea Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 46. India Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 48. South America Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Figure 49. South America Cancer Cachexia Revenue Market Share by Countries in 2019
Figure 50. Brazil Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Cancer Cachexia Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Cancer Cachexia Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 55. UAE Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Cancer Cachexia Revenue and Growth Rate (2015-2020)
Figure 58. Global Cancer Cachexia Revenue Share by Type (2015-2020)
Figure 59. Global Cancer Cachexia Revenue Share by Type in 2019
Figure 60. Global Cancer Cachexia Market Share Forecast by Type (2021-2025)
Figure 61. Global Progestogens Revenue Growth Rate (2015-2020)
Figure 62. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 63. Global Combination therapies Revenue Growth Rate (2015-2020)
Figure 64. Global Cancer Cachexia Revenue Share by Application (2015-2020)
Figure 65. Global Cancer Cachexia Revenue Share by Application in 2019
Figure 66. Global Cancer Cachexia Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Stores Revenue Growth Rate (2015-2020)
Figure 68. Global Retails Pharmacy Store Revenue Growth Rate (2015-2020)
Figure 69. Global Online Pharmacy Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Cachexia Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Cancer Cachexia Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Cancer Cachexia Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Cancer Cachexia Revenue Market Forecast (2021-2025)
Figure 74. Europe Cancer Cachexia Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Cancer Cachexia Revenue Market Forecast (2021-2025)
Figure 76. South America Cancer Cachexia Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Cancer Cachexia Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
がん悪液質の世界市場（～2026年） Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. Market Analysis and Insights: Global Cancer Cachexia Market The global Cancer Cachexia mark…- がんによる性食欲不振-悪液質症候群医薬品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Anorexia-Cachexia Syndrome Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer…
- 癌性食欲不振-悪液質症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cancer Anorexia-Cachexia Syndrome Drug Market The global Cancer Anorexia-Cachexia Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Anorexia-Cachexia Syndrome Dru…
- がん治療の世界市場（～2026年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…
- 精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…